Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil vs fentanyl in mechanically ventilated cardiogenic shock
ChiCTR2600117902Phase 4Not yet recruiting
- Sponsor
- The First Hospital of Jilin University
- Start
- Jan 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in cardiogenic shock comparing Remifentanil arm with Fentanyl arm (2 arms). Primary endpoint: 24-hour lactate clearance rate. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
remifentanilfentanyl
03
Conditions
cardiogenic shock
Beyond the preview
Go deeper on ChiCTR2600117902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600117902.